DGNMF (Diagnamed Holdings) Common Stock: $3.52 Mil (As of Mar. 2026)


What is Diagnamed Holdings Common Stock?

Diagnamed Holdings DGNMF Common Stock is $3.52 Mil as of Mar. 2026. The stock has 1 warning sign investors should review.

Diagnamed Holdings's quarterly common stock increased from Sep. 2025 ($3.09 Mil) to Dec. 2025 ($3.29 Mil) and increased from Dec. 2025 ($3.29 Mil) to Mar. 2026 ($3.52 Mil).

Diagnamed Holdings's annual common stock declined from Sep. 2023 ($2.64 Mil) to Sep. 2024 ($2.64 Mil) but then increased from Sep. 2024 ($2.64 Mil) to Sep. 2025 ($3.09 Mil).

Diagnamed Holdings Common Stock Historical Data

* Premium members only.

The historical data trend for Diagnamed Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnamed Holdings Common Stock Chart

Diagnamed Holdings Annual Data
Trend Sep21 Sep22 Sep23 Sep24 Sep25
Common Stock
2.46 2.38 2.64 2.64 3.09

Diagnamed Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.60 3.30 3.09 3.29 3.52

Diagnamed Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $3.52 Mil mean?
Diagnamed Holdings (DGNMF) has a Common Stock of $3.52 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Diagnamed Holdings and its competitors.
Is Diagnamed Holdings' Common Stock too high?
Diagnamed Holdings' current Common Stock is $3.52 Mil.
How does Diagnamed Holdings' Common Stock compare to VEEV and BTSG?
Diagnamed Holdings' Common Stock of $3.52 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Healthcare Providers & Services company?
A good Common Stock depends on the Healthcare Providers & Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Diagnamed Holdings and its competitors. Diagnamed Holdings's current Common Stock is $3.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnamed Holdings stock overvalued right now?
Diagnamed Holdings (DGNMF) has a current Common Stock of $3.52 Mil. The current Common Stock is $3.52 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Diagnamed Holdings (DGNMF), the current Common Stock is $3.52 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diagnamed Holdings Business Description

Other Exchanges DMED:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.